We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+4.06%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$8.02B
AUM Growth
+$201M
Cap. Flow
-$89M
Cap. Flow %
-1.11%
Top 10 Hldgs %
19.81%
Holding
867
New
76
Increased
308
Reduced
302
Closed
63

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$48.8M
2
PG icon
Procter & Gamble
PG
+$24.6M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$23.6M
4
KEYS icon
Keysight
KEYS
+$23.2M
5
BMY icon
Bristol-Myers Squibb
BMY
+$21.2M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$46.5M
2
XOM icon
ExxonMobil
XOM
+$36.6M
3
GG
Goldcorp Inc
GG
+$24.9M
4
DIS icon
Walt Disney
DIS
+$23.8M
5
NAVG
Navigators Group Inc
NAVG
+$19.1M

Sector Composition

Rank Sector Weight
1 Healthcare 33.16%
2 Technology 16.87%
3 Financials 10.38%
4 Consumer Discretionary 9.09%
5 Communication Services 7.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.99T
$239M 2.98%
1,745,833
+56,437
+3% +$7.16M
AMGN icon
2
Amgen
AMGN
$197B
$189M 2.35%
1,021,605
+6,646
+0.7% +$1.19M
VRTX icon
3
Vertex Pharmaceuticals
VRTX
$122B
$172M 2.14%
940,506
+278,986
+42% +$48.8M
GOOGL icon
4
Alphabet (Google) Class A
GOOGL
$4.3T
$153M 1.91%
2,794,040
+408,100
+17% +$23.6M
AMZN icon
5
Amazon
AMZN
$2.69T
$149M 1.86%
1,580,620
+93,440
+6% +$8.7M
BIIB icon
6
Biogen
BIIB
$29.5B
$145M 1.81%
624,720
-29,775
-5% -$6.88M
MRK icon
7
Merck
MRK
$307B
$141M 1.76%
1,757,430
+124,976
+8% +$9.57M
AAPL icon
8
Apple
AAPL
$4.8T
$138M 1.72%
2,681,528
-350,928
-12% -$17.1M
GILD icon
9
Gilead Sciences
GILD
$165B
$134M 1.67%
1,976,025
-23,239
-1% -$1.53M
META icon
10
Meta Platforms (Facebook)
META
$1.64T
$128M 1.6%
667,996
+101,764
+18% +$18.6M
BABA icon
11
Alibaba
BABA
$288B
$126M 1.57%
745,971
+63,623
+9% +$11M
REGN icon
12
Regeneron Pharmaceuticals
REGN
$70.5B
$120M 1.5%
385,741
+38,470
+11% +$12.8M
BMY icon
13
Bristol-Myers Squibb
BMY
$123B
$110M 1.37%
2,427,885
+454,646
+23% +$21.2M
PG icon
14
Procter & Gamble
PG
$347B
$108M 1.34%
953,891
+230,953
+32% +$24.6M
ILMN icon
15
Illumina
ILMN
$27.9B
$91.4M 1.14%
256,467
+19,606
+8% +$6.19M
V icon
16
Visa
V
$686B
$75.8M 0.95%
415,891
-28,263
-6% -$4.63M
ALXN
17
DELISTED
Alexion Pharmaceuticals
ALXN
$73.7M 0.92%
565,233
+181
+0% +$23.3K
DIS icon
18
Walt Disney
DIS
$167B
$73.2M 0.91%
491,477
-179,766
-27% -$23.8M
CELG
19
DELISTED
Celgene Corp
CELG
$70.2M 0.88%
762,400
-489,524
-39% -$46.5M
CSCO icon
20
Cisco
CSCO
$436B
$68.3M 0.85%
1,225,854
+87,179
+8% +$4.81M
JNJ icon
21
Johnson & Johnson
JNJ
$599B
$62.2M 0.78%
412,532
+13,912
+3% +$1.93M
ABT icon
22
Abbott
ABT
$177B
$59.9M 0.75%
715,817
+150,066
+27% +$11.8M
PEP icon
23
PepsiCo
PEP
$185B
$55.8M 0.7%
400,571
+35,503
+10% +$4.55M
HD icon
24
Home Depot
HD
$332B
$53.1M 0.66%
236,309
-73,637
-24% -$14.7M
VZ icon
25
Verizon
VZ
$182B
$46.9M 0.59%
753,128
-54,550
-7% -$3.14M
1
2 3 4 5

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q2 2019 Portfolio in Review

As of Q2 2019, Candriam SCA held 867 positions worth $8.02B, up 2.6% from $7.82B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Candriam SCA's Q2 2019 filing shows 76 new, 308 increased, 302 reduced and 63 closed positions. Its largest new stake was Total System Services, Inc.: 112,342 shares worth $14.3M. The largest sale was Celgene Corp, an estimated $46.5M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q2 2019 buy was Total System Services, Inc.: 112,342 shares worth $14.3M.
  • Candriam SCA added most to Vertex Pharmaceuticals in Q2 2019, an estimated $48.8M increase.
  • Candriam SCA's biggest Q2 2019 reduction was Celgene Corp, cutting an estimated $46.5M.
  • Candriam SCA fully exited Goldcorp Inc in Q2 2019, selling an estimated $24.9M.
  • Candriam SCA's ten largest holdings make up 20% of its $8.02B portfolio in Q2 2019.
  • Candriam SCA opened 76 new positions and closed 63 in Q2 2019.
  • Candriam SCA's portfolio value rose 2.6% quarter-over-quarter to $8.02B.

Based on Candriam SCA's 13F filing for Q2 2019, filed 1 Aug 2019.